The two things that changed
2025 — the shortages ended. The FDA declared the tirzepatide shortage resolved in December 2024 and the semaglutide shortage resolved in February 2025. That closed the legal window under which compounders could produce copies of the drugs at scale.
2026 — manufacturers cut self-pay prices. Novo Nordisk now sells Wegovy directly at $149/month for the pill and $199/month for the pen. Eli Lilly sells Zepbound self-pay from $299/month. The cost argument for compounded medication is much weaker than it was.
What Compounding Actually Is
Compounding is a normal, legal part of pharmacy. A licensed pharmacist combines or alters ingredients to make a medication tailored to an individual patient — a liquid version for someone who cannot swallow tablets, a dye-free formulation for someone with an allergy, a dose that is not commercially available.
Two categories matter here. 503A pharmacies compound for individual patients against a specific prescription. 503B outsourcing facilities can produce larger batches and are subject to tighter FDA oversight, though their products are still not FDA-approved.
During a declared shortage, federal law allows compounders more latitude to produce versions of a commercially available drug. That is the provision the entire compounded GLP-1 industry was built on between 2023 and 2025, and it is the provision that closed when the shortages resolved.
The Timeline
- 2023–2024: Semaglutide and tirzepatide both on the FDA shortage list. Compounded versions proliferate across telehealth.
- December 2024: FDA declares the tirzepatide shortage resolved.
- February 2025: FDA declares the semaglutide shortage resolved.
- April 22, 2025: Deadline for 503A pharmacies to stop compounding semaglutide.
- May 22, 2025: Deadline for 503B outsourcing facilities to stop compounding semaglutide.
- Late 2025: FDA approves oral semaglutide (the Wegovy pill), the first oral GLP-1 for chronic weight management. Launch in the US follows in early January 2026.
- April 2026: FDA approves Lilly's Foundayo (orforglipron), an oral GLP-1 pill for weight loss.
- July 1, 2026: Medicare GLP-1 Bridge program begins, capping eligible GLP-1s at $50/month for Part D beneficiaries.
How Compounded GLP-1s Still Exist
If the window closed, why can you still buy compounded semaglutide from a dozen telehealth companies? Because compounding for an individual patient never stopped being legal. What ended was the shortage-era latitude to produce what amounts to a copy of the commercial product.
Companies now generally frame their products as personalized formulations prescribed for a specific patient — a microdose that falls between the approved titration steps, or semaglutide combined with vitamin B12 or B6. Brello, for instance, sells compounded semaglutide and tirzepatide “with B6 (pyridoxine).” Noom publishes a Microdose GLP-1Rx program.
Whether those formulations genuinely constitute personalized compounding, or are a workaround for the restriction, is actively disputed. The FDA has signaled further action, and there is no guarantee your provider will be able to keep supplying compounded medication indefinitely.
What this means practically
Do not prepay for six or twelve months of compounded medication on the assumption that the supply is guaranteed. Providers that also offer FDA-approved medication — Mochi, Found, Eden — can at least transition you if the rules tighten. Compounded-only providers cannot.
Also note: adding a vitamin to a GLP-1 has no clinical trial evidence showing it improves weight-loss outcomes. If a provider markets the B12 or B6 as a benefit rather than a formulation detail, treat that as marketing.
Side by Side
| Brand-name (FDA-approved) | Compounded | |
|---|---|---|
| FDA review | Full review of safety, efficacy, potency, and manufacturing | None — not FDA-approved |
| Cost (semaglutide) | $149/mo pill, $199/mo pen via NovoCare self-pay | $70–$299/mo medication, usually plus membership |
| Cost (tirzepatide) | $299–$699/mo by dose via LillyDirect self-pay | $100–$375/mo medication, usually plus membership |
| Insurance | Coverage possible; copays can be very low | Never covered, anywhere |
| Medicare GLP-1 Bridge | Eligible drugs capped at $50/mo | Not eligible |
| Dose flexibility | Fixed approved titration schedule | Microdoses and intermediate steps available |
| Formats | Injection pens, vials, and oral tablets | Injections, plus oral and sublingual at some providers |
| Supply certainty | Manufacturer supply chain | Depends on evolving FDA enforcement |
| Clinical trial evidence | Tied to the exact product and schedule | None for the specific formulation |
Who Should Choose Which
Brand-name makes more sense if
- You have any insurance coverage for GLP-1s — compounded is never reimbursable.
- You are on Medicare and may qualify for the $50/month Bridge program.
- You want semaglutide specifically, where brand-name self-pay is now genuinely cheap.
- You want the certainty of a reviewed, verified product.
- You want an FDA-approved oral option (Wegovy tablets or Foundayo) rather than a compounded oral formulation.
Compounded may still make sense if
- You want tirzepatide at a maintenance dose, where compounded flat pricing beats $699/month.
- Your prescriber has a specific clinical reason for a dose between the approved steps.
- You want to microdose and understand that this is not an FDA-approved dosing strategy.
- You have no insurance and the very lowest compounded prices genuinely beat your alternatives.
What to Ask Before Buying Compounded
- Which pharmacy fills this — a 503A pharmacy or a 503B outsourcing facility? Is it licensed in my state?
- Is anything added to the semaglutide or tirzepatide, and why?
- What happens to my plan if regulations change mid-term?
- Is there testing for potency and sterility, and can I see the results?
- What is the refund position if I prepay and cannot tolerate the medication?
A provider that answers these clearly is doing something most of the market does not. In our reviews, we note specifically which providers name their pharmacy and which do not.
Frequently Asked Questions
What is a compounded GLP-1?
A version of semaglutide or tirzepatide prepared by a compounding pharmacy rather than the original manufacturer. Compounding is a long-standing, legal pharmacy practice for making medications tailored to individual patients. Compounded products are not FDA-approved, which means their potency, purity, and consistency have not been reviewed the way an approved drug's are.
Are compounded GLP-1s still available?
Many telehealth companies still offer them, but the basis changed. The FDA declared the tirzepatide shortage resolved in December 2024 and the semaglutide shortage resolved in February 2025, ending the window for compounders to make copies — 503A pharmacies had until April 22, 2025 and 503B outsourcing facilities until May 22, 2025. Companies continuing to offer them generally frame them as patient-specific personalized formulations, often microdoses or versions combined with a vitamin. That practice remains legally contested.
Are compounded GLP-1s safe?
They contain the same active molecules, so the mechanism is the same. What differs is verification. An FDA-approved product has been through review of its manufacturing, potency, and purity. A compounded product has not. Reputable providers source from licensed US pharmacies, which reduces risk considerably compared to unregulated sellers — but it is not the same assurance as FDA approval. Discuss the trade-off with your prescriber.
Is brand-name still more expensive?
Much less than it used to be. NovoCare Pharmacy publishes brand-name Wegovy at $149/month for the pill and $199/month for the pen. Amazon One Medical publishes oral GLP-1s from $149/month cash-pay. Once you add the membership fees most compounded providers charge, brand-name semaglutide is now competitive with or cheaper than several compounded options.
Related Reading
- Best compounded GLP-1 providers — total cost, not headline price
- What GLP-1s actually cost in 2026
- Insurance coverage guide
- Storage and shipping — cold chain matters more for shipped compounded medication
Medical Disclaimer
We're not doctors, and this article is for education only — it isn't medical advice. GLP-1 medications are prescription-only and require evaluation by a licensed healthcare provider. Individual results vary widely, and only a clinician who knows your history can determine what is safe and appropriate for you. See our full medical disclaimer.
Keep Comparing
Every provider we've researched, with published pricing, medication type, and what's actually included.
Affiliate Disclosure: This article may contain affiliate links. If you sign up through one, we may earn a commission at no additional cost to you. We do not accept payment for favorable coverage. Read our full affiliate disclosure policy.